ClinicalTrials.gg
RecruitingNCT06114706BASTAUpdated Mar 16, 2026

Best Assessment of Sore Throat and Antibiotic Prescribing

An interventional study of Physicians assess patients and Nurses assess patients in Pharyngitis, sponsored by Vastra Gotaland Region. Recruiting at 4 sites in Sweden. Open to participants aged 6 Years and older. Per ClinicalTrials.gov, last updated 2026-03-16.

Sponsored by Vastra Gotaland Region · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Non-randomized
Ages
6 Years and older
Sex
All
01

Study summary

This project aims to investigate if an organisational change of patient flow away from medical practitioners can reduce unnecessary antibiotic prescribing in patients attending with a sore throat as the main complaint.

Read the detailed description

Today patients appear either at a PHC centre or at the Pharmacy. The Pharmacy may provide advice on analgesic or refer the patient to a PHC centre. At the PHC centre, the patient may first appear to the medical practitioner or a nurse pending on local routines. The current Swedish guideline recommends no antibiotics and no testing for patients with 0-2 Centor criteria. For patients with 3-4 Centor criteria the guideline recommends testing and only consider antibiotics if GAS is present.

COVID-19 has gradually transformed from expressing itself as a severe lower respiratory tract infection to be more of an upper respiratory tract infection. Furthermore, COVID-19 is likely to transform from a pandemic to an endemic state with a low continuous incidence. Hence, in response to COVID-19 it seems crucial to identify to what extent the common sore throat is caused by the SARS-CoV-2.

Furthermore, a large controlled clinical trial is required to sort out if patients attending with a sore throat as the main complaint are best managed by medical practitioners, nurses or pharmacists. This study aims to perform such a controlled clinical trial comparing the outcome of sore throat patients management by medical practitioner, nurses and pharmacists. This study also aims to investigate to what extent the SARS-CoV-2 virus is identified in these patients.

02

Conditions studied

  • Pharyngitis

Browse trials for

Keywords

  • Guideline
  • Sore throat
  • Pharmacy
  • Nurses
  • Physicians
03

In context

Pharyngitis

226 studies on the registry are indexed under Pharyngitis; 35 are open to participants now.

This study's planned enrollment of 450 is above the median of 144 across 188 interventional studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

Vastra Gotaland Region is the lead sponsor of 275 studies on the registry; 109 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patient is contacting/attending PHC centre or Pharmacy presenting with a sore throat as the main complaint.
  • Male or female, aged ≥6 years.
  • Fluent in Swedish (reading, writing, conversational) (applicable to caregivers/parents/guardians in case of children).
  • Mental state such that he or she can understand and give to participation in the study by signing the Information and Consent Form.
  • Provision of signed and dated Informed Consent Form.

Exclusion criteria

Exclusion Criteria:

  • The illness episode is classified as potentially complicated or potentially critically ill
  • Presence of SARS-CoV-2 virus in a patient first appearing at the PHC in a cluster where the assessment is supposed to be done by the pharmacists. The patient will not be sent to the pharmacist in case of presence of SARS-CoV-2-virus.
  • Patient request to be withdrawn from the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
450 participants (estimated)

Study arms

  • Active comparator
    Initial assessement by physicians

    Patients attending with an acute sore throat are initially assessed by a physician. This is one variant of current standard practice.

    Behavioral: Physicians assess patients

  • Active comparator
    Initial assessement by nurses

    Patients attending with an acute sore throat are initially assessed by a nurse. This is one variant of current standard practice.

    Behavioral: Nurses assess patients

  • Experimental
    Initial assessement by pharmacists

    Patients attending with an acute sore throat are initially assessed by a pharmacist. This is officially not standard practice in Sweden, although it happens.

    Behavioral: Pharmacists assess patients

Interventions

  • BehavioralPhysicians assess patients

    Physicians are asked to assess patients following the current Swedish guideline

  • BehavioralNurses assess patients

    Nurses are asked to assess patients following the current Swedish guideline

  • BehavioralPharmacists assess patients

    Pharmacists are asked to assess patients following the current Swedish guideline

06

What researchers measure

Primary outcomes

  1. Guideline adherence

    Will the proportion of patients attending for an uncomplicated acute sore throat being managed according to prevailing guidelines differ if the initial assessment is made by a medical practitioner, a trained nurse or a trained pharmacist

    Time frame: Immediately after the consultation

Secondary outcomes

  1. Illness severity

    What proportion of patients attending PHC centres or pharmacies are classified as apparently uncomplicated, potentially complicated or potentially critically ill

    Time frame: Immediately after the consultation

  2. Type of patients seeking care

    Will patient characteristics differ if the patient first appears to the medical practitioner, a trained nurse or a trained pharmacist?

    Time frame: Immediately after the consultation

  3. Presence of SARS-CoV-2 virus

    To what extent do patients attending Primary Health Care/Pharmacies due to an acute sore throat harbour the SARS-CoV-2 virus?

    Time frame: Immediately after the consultation

07

Study locations

4 of 4 sites recruiting
  • Apoteket
    Stenungsund, 4430, Sweden
    Recruiting
    • Mina Khalil · Contact
  • Närhälsan Stenungsund Vårdcentral
    Stenungsund, 44430, Sweden
    Recruiting
    • Annelie Jardek · Contact
  • Praktikertjänst Hälsobrunnen Vårdcentral
    Ulricehamn, 52337, Sweden
    Recruiting
    • Dennis Johansson · Contact
  • Apoteksgruppen
    Ulricehamn, Sweden
    Recruiting
    • Sofia Pihlgren · Contact
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06114706
Responsible party
Sponsor
First posted
Nov 2, 2023
Start date
Mar 4, 2024
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Mar 16, 2026

Study contacts

Carl Wikberg, PhD
Contact
carl.wikberg@allmed.gu.se
+46703821660
Ronny Gunnarsson, PhD
principal investigator · University of Gothenburg and Region Vastra Gotaland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion